By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck KGaA 

Frankfurter Street 250

Darmstadt    D-64293  Germany
Phone: 49-6151-720 Fax: 49-6151-722000




SmithKline Beecham 

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in diabetes and obesity.

GlaxoSmithKline (North Carolina) 

TargeGen, Inc.  Licensing Agreement - Vascular Biology Portfolio.

Company News
Merck KGaA (MKGAF.PK) Release: EMA's CHMP Issues Positive Opinion For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma 7/21/2017 7:25:12 AM
Merck KGaA (MKGAF.PK) to Shutter Four Sites, Lay Off 200 Employees 7/13/2017 6:05:06 AM
Merck KGaA (MKGAF.PK) Awards €1.25 Million To Research Projects Through Its 2017 Grant For Fertility Innovation (GFI) 7/5/2017 10:26:55 AM
eFFECTOR To Collaborate With Pfizer (PFE) And Merck KGaA (MKGAF.PK), Darmstadt, Germany To Evaluate A Novel Immuno-Oncology Combination In Microsatellite Stable Colorectal Cancer 6/20/2017 6:47:31 AM
Human Longevity Announces Agreement With Merck KGaA (MKGAF.PK), Darmstadt, Germany To Engage In Cancer Biomarker Discovery In Advanced Melanoma 6/15/2017 9:18:21 AM
BioMed X And Merck KGaA (MKGAF.PK) Launch Two New Crowdsourcing Projects In The Fields Of Cancer Research And Biologics Manufacturing 6/8/2017 9:39:54 AM
New Immuno-Onco Deal With Merck KGaA (MKGAF.PK) Could Make This UK Biotech a $1 Billion Company 6/5/2017 6:55:35 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany Licenses Selexis SA Suretechnology Platform For Immuno-Oncology Antibody Program 5/30/2017 9:11:29 AM
David Braun, Head Of Merck KGaA (MKGAF.PK) Device Business (MD&S), Joins Cellect (APOP)'s Advisory Board 5/23/2017 7:39:06 AM
Merck KGaA (MKGAF.PK) Ponders Over Shifting Certain Businesses Into Subsidiaries 5/16/2017 6:15:57 AM